✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Novartis

Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
75,267
Ticker
NOVN
Exchange
SIX SWISS EXCHANGE
Description
Novartis AG is a Swiss multinational pharmaceutical corporation headquartered in Basel, one of the world's largest manufacturers of innovative medicines. Formed in 1996 through the historic merger of ...

Novartis's Financial Statements Preview

Below are the financial statements of Novartis, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Net sales from continuing operations
50,317a
45,440a
42,206a
Other revenues
1,405a
1,220a
1,255a
Cost of goods sold
-12,827a
-12,472a
-11,582a
Gross profit from continuing operations
38,895a
34,188a
31,879a
Selling, general and administration
-12,566a
-12,517a
-12,193a
Research and development
-10,022a
-11,371a
-9,172a
Other income
1,175a
1,772a
696a
Other expense
-2,938a
-2,303a
-3,264a
Operating income from continuing operations
14,544a
9,769a
7,946a
Loss from associated companies
-38a
-13a
-11a
Interest expense
-1,006a
-855a
-800a
Other financial income and expense
140a
222a
42a
Income before taxes from continuing operations
13,640a
9,123a
7,177a
Income taxes
-1,701a
-551a
-1,128a
Net income from continuing operations
11,939a
8,572a
6,049a
Net income from discontinued operations before gain on distribution of Sandoz Group AG to Novartis AG shareholders
0a
422a
906a
Gain on distribution of Sandoz Group AG to Novartis AG shareholders
0a
5,860a
0a
Net income from discontinued operations
0a
6,282a
906a
Net income
11,939a
14,854a
6,955a
Attributable to
Shareholders of Novartis AG
11,941a
14,850a
6,955a
Non-controlling interests
-2a
4a
0a
Limited Data Preview
You are viewing a limited preview of Novartis’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Novartis’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novartis’s data sources below and access millions more through our Disclosure Search.

a. Novartis's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?